EDGAR Filing Documents for 0001144204-17-018349

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001144204-17-018349

Filing Date

2017-04-03

Accepted

2017-04-03 07:00:54

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	v463055_s3.htm	S-3	305089
2	EXHIBIT 4.1	v463055_ex4-1.htm	EX-4.1	1252
3	EXHIBIT 4.5	v463055_ex4-5.htm	EX-4.5	423691
4	EXHIBIT 4.6	v463055_ex4-6.htm	EX-4.6	454019
5	EXHIBIT 5.1	v463055_ex5-1.htm	EX-5.1	23243
6	EXHIBIT 23.1	v463055_ex23-1.htm	EX-23.1	3664
7	GRAPHIC	logo_s3.jpg	GRAPHIC	18808
8	GRAPHIC	ex4-1pg1.jpg	GRAPHIC	63736
9	GRAPHIC	ex4-1pg2.jpg	GRAPHIC	48519
	Complete submission text file	0001144204-17-018349.txt		1392820

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921

Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860

Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)